Citation of paper, Cost-Effectiveness of Sequential Teriparatide/Alendronate Versus Alendronate-Alone Strategies in High-Risk Osteoporotic Women in the US: Analyzing the Impact of Generic/Biosimilar Teriparatide

Authors Citing This Paper

AuthorCiting PapersAuthor's PapersAuthor's CitationsAuthor's IF
10
Mickael Hiligsmann11893,1623.2
Joop P Van Den Bergh11462,6823.2
D Vivas-Consuelo1354001.3
Barbara Hauser1131291
Silvia M A A Evers13097,0232.6
Silvia González de Julián17384.3
Nerea Alonso1251,8898.7
Michael McClung121019,0618.2
Ingrid Lindberg14142.3

Journals Citing This Paper